Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).

Article Details

Citation

Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV

Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).

Science. 1991 Apr 5;252(5002):120-3.

PubMed ID
1672777 [ View in PubMed
]
Abstract

The natriuretic peptides are hormones that can stimulate natriuretic, diuretic, and vasorelaxant activity in vivo, presumably through the activation of two known cell surface receptor guanylyl cyclases (ANPR-A and ANPR-B). Although atrial natriuretic peptide (ANP) and, to a lesser extent, brain natriuretic peptide (BNP) are efficient activators of the ANPR-A guanylyl cyclase, neither hormone can significantly stimulate ANPR-B. A member of this hormone family, C-type natriuretic peptide (CNP), potently and selectively activated the human ANPR-B guanylyl cyclase. CNP does not increase guanosine 3',5'-monophosphate accumulation in cells expressing human ANPR-A. The affinity of CNP for ANPR-B is 50- or 500-fold higher than ANP or BNP, respectively. This ligand-receptor pair may be involved in the regulation of fluid homeostasis by the central nervous system.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Atrial natriuretic peptide receptor 1P16066Details
Natriuretic peptides BP16860Details
Atrial natriuretic peptide receptor 2P20594Details